0001662118-18-000001.txt : 20180122 0001662118-18-000001.hdr.sgml : 20180122 20180122124423 ACCESSION NUMBER: 0001662118-18-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180122 DATE AS OF CHANGE: 20180122 EFFECTIVENESS DATE: 20180122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Petra Pharma Corp CENTRAL INDEX KEY: 0001662118 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-254662 FILM NUMBER: 18539329 BUSINESS ADDRESS: STREET 1: 430 EAST 29TH STREET CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: (206) 957-7300 MAIL ADDRESS: STREET 1: 430 EAST 29TH STREET CITY: NEW YORK STATE: NY ZIP: 10016 D/A 1 primary_doc.xml X0708 D/A LIVE 0001662118 Petra Pharma Corp 450 E 29th St., Suite 506 NEW YORK NY NEW YORK 10016 646-440-9210 DELAWARE None None Corporation true 2015 Thong Le c/o Petra Pharma Corporation 450 E 29th St., Suite 506 New York NY NEW YORK 10016 Director Promoter Steve Gillis c/o Petra Pharma Corporation 450 E 29th St., Suite 506 New York NY NEW YORK 10016 Director M. Johnston Erwin c/o Petra Pharma Corporation 450 E 29th St., Suite 506 New York NY NEW YORK 10016 Director Barbara Dalton c/o Petra Pharma Corporation 450 E 29th St., Suite 506 New York NY NEW YORK 10016 Director Joel Marcus c/o Petra Pharma Corporation 450 E 29th St., Suite 506 New York NY NEW YORK 10016 Director Paul Sekhri c/o Petra Pharma Corporation 450 E 29th St., Suite 506 New York NY NEW YORK 10016 Director Brian O'Callaghan c/o Petra Pharma Corporation 450 E 29th St., Suite 506 New York NY NEW YORK 10016 Executive Officer Director David McElligott c/o Petra Pharma Corporation 450 E 29th St., Suite 506 New York NY NEW YORK 10016 Executive Officer Promoter David Renas c/o Petra Pharma Corporation 450 E 29th St., Suite 506 New York NY NEW YORK 10016 Executive Officer Albert Yu c/o Petra Pharma Corporation 450 E 29th St., Suite 506 New York NY NEW YORK 10016 Executive Officer Promoter Lindsay Rayle c/o Petra Pharma Corporation 450 E 29th St., Suite 506 New York NY NEW YORK 10016 Promoter David Schubert c/o Petra Pharma Corporation 450 E 29th St., Suite 506 New York NY NEW YORK 10016 Promoter Biotechnology Decline to Disclose 06b true 0001662114-17-000002 2015-12-23 true true false 0 48250000 31204516 17045484 false 13 0 0 0 false Petra Pharma Corp /s/ David Renas David Renas Chief Financial Officer 2018-01-22